Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Abstract PS2-19: Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC)

Ozge Gumusay, Mark Jesus M. Magbanua, Melanie C. Majure, Travis Deal, Jonathan R. Renslo, Chiara A. Wabl, Michelle E. Melisko, A. Jo Chien, Andrei Goga, Mark M. Moasser, John W. Park, Jimmy Hwang, Hope S. Rugo

Cancer Res (2021) 81 (4_Supplement): PS2-19.

https://doi.org/10.1158/1538-7445.SABCS20-PS2-19

Published: 15 February 2021

View articletitled, Abstract PS2-19: Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC)

Journal Articles

Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer

Cancer Res (2017) 77 (16): 4530–4541.

https://doi.org/10.1158/0008-5472.CAN-17-0688

Published: 14 August 2017

View articletitled, Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer

Includes: Supplementary data

Journal Articles

Abstract P3-06-15: Evaluation of HER family protein signaling network as a predictive biomarker for pCR for breast cancer patients treated with neratinib in the I-SPY 2 trial

Cancer Res (2015) 75 (9_Supplement): P3-06-15.

https://doi.org/10.1158/1538-7445.SABCS14-P3-06-15

Published: 01 May 2015

View articletitled, Abstract P3-06-15: Evaluation of HER family protein signaling network as a predictive biomarker for pCR for breast cancer patients treated with neratinib in the I-SPY 2 trial

Journal Articles

Abstract P3-06-29: MammaPrint High1/High2 risk class as a biomarker of response to neratinib plus standard neoadjuvant therapy for breast cancer in the I-SPY 2 TRIAL

Cancer Res (2015) 75 (9_Supplement): P3-06-29.

https://doi.org/10.1158/1538-7445.SABCS14-P3-06-29

Published: 01 May 2015

View articletitled, Abstract P3-06-29: MammaPrint High1/High2 risk class as a biomarker of response to neratinib plus standard neoadjuvant therapy for breast cancer in the I-SPY 2 TRIAL

Journal Articles

Abstract CT227: Neratinib plus standard neoadjuvant therapy for high-risk breast cancer: Efficacy results from the I-SPY 2 TRIAL

Cancer Res (2014) 74 (19_Supplement): CT227.

https://doi.org/10.1158/1538-7445.AM2014-CT227

Published: 01 October 2014

View articletitled, Abstract CT227: Neratinib plus standard neoadjuvant therapy for high-risk breast cancer: Efficacy results from the I-SPY 2 TRIAL

Journal Articles

Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis

Mark Jesus M. Magbanua, Michelle Melisko, Ritu Roy, Eduardo V. Sosa, Louai Hauranieh, Andrea Kablanian, Lauren E. Eisenbud, Artem Ryazantsev, Alfred Au, Janet H. Scott, John W. Park

Cancer Res (2013) 73 (23): 7134–7143.

https://doi.org/10.1158/0008-5472.CAN-13-2051

Published: 01 December 2013

View articletitled, Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis

Includes: Supplementary data

Journal Articles

Genomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer Patients

Mark Jesus M. Magbanua, Eduardo V. Sosa, Ritu Roy, Lauren E. Eisenbud, Janet H. Scott, Adam Olshen, Dan Pinkel, Hope S. Rugo, John W. Park

Cancer Res (2013) 73 (1): 30–40.

https://doi.org/10.1158/0008-5472.CAN-11-3017

Published: 02 January 2013

View articletitled, Genomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer Patients

Includes: Supplementary data

Journal Articles

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Dmitri B. Kirpotin, Daryl C. Drummond, Yi Shao, M. Refaat Shalaby, Keelung Hong, Ulrik B. Nielsen, James D. Marks, Christopher C. Benz, John W. Park

Cancer Res (2006) 66 (13): 6732–6740.

https://doi.org/10.1158/0008-5472.CAN-05-4199

Published: 03 July 2006

View articletitled, Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Journal Articles

Anthracylines can bypass multidrug-resistance mechanisms via receptor-specific immunoliposomal delivery in EGFR overexpressing tumor cells

Christoph Mamot, Willy Kueng, Reto Ritschard, Richard Herrmann, John W. Park, Christoph Rochlitz

Cancer Res (2006) 66 (8_Supplement): 721–722.

Published: 15 April 2006

View articletitled, Anthracylines can bypass multidrug-resistance mechanisms via receptor-specific immunoliposomal delivery in EGFR overexpressing tumor cells

Journal Articles

Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy

Daryl C. Drummond, Charles O. Noble, Zexiong Guo, Keelung Hong, John W. Park, Dmitri B. Kirpotin

Cancer Res (2006) 66 (6): 3271–3277.

https://doi.org/10.1158/0008-5472.CAN-05-4007

Published: 15 March 2006

View articletitled, Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy

Journal Articles

Novel Nanoliposomal CPT-11 Infused by Convection-Enhanced Delivery in Intracranial Tumors: Pharmacology and Efficacy

Charles O. Noble, Michal T. Krauze, Daryl C. Drummond, Yoji Yamashita, Ryuta Saito, Mitchel S. Berger, Dmitri B. Kirpotin, Krystof S. Bankiewicz, John W. Park

Cancer Res (2006) 66 (5): 2801–2806.

https://doi.org/10.1158/0008-5472.CAN-05-3535

Published: 01 March 2006

View articletitled, Novel Nanoliposomal CPT-11 Infused by Convection-Enhanced Delivery in Intracranial Tumors: Pharmacology and Efficacy

Journal Articles

Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs In vivo

Christoph Mamot, Daryl C. Drummond, Charles O. Noble, Verena Kallab, Zexiong Guo, Keelung Hong, Dmitri B. Kirpotin, John W. Park

Cancer Res (2005) 65 (24): 11631–11638.

https://doi.org/10.1158/0008-5472.CAN-05-1093

Published: 15 December 2005

View articletitled, Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs In vivo

Journal Articles

Breast cancer phenotypes and responsiveness to bortezomib therapy.

Corina Marx, Yamei Zhou, John W. Park, Christopher C. Benz

Cancer Res (2005) 65 (9_Supplement): 108.

Published: 01 May 2005

View articletitled, Breast cancer phenotypes and responsiveness to bortezomib therapy.

Journal Articles

Development of novel liposomal and receptor tyrosine kinase-targeted immunoliposomal vinorelbine formulations with improved drug retention

Daryl C. Drummond, Charles O. Noble, Christoph Mamot, Zexiong Guo, Keelung Hong, John W. Park, James D. Marks, Dmitri B. Kirpotin

Cancer Res (2005) 65 (9_Supplement): 1039–1040.

Published: 01 May 2005

View articletitled, Development of novel liposomal and receptor tyrosine kinase-targeted immunoliposomal vinorelbine formulations with improved drug retention

Journal Articles

Liposomal and immunoliposomal therapeutics for brain tumors: biodistribution, imaging, and efficacy following convection-enhanced delivery

Charles O. Noble, Ryuta Saito, Michal Krauze, Daryl C. Drummond, Dmitri B. Kirpotin, John R. Bringas, Tracy McKnight, Mitchel S. Berger, Krys S. Bankiewicz, John W. Park

Cancer Res (2005) 65 (9_Supplement): 1039.

Published: 01 May 2005

View articletitled, Liposomal and immunoliposomal therapeutics for brain tumors: biodistribution, imaging, and efficacy following convection-enhanced delivery

Journal Articles

Development of a highly stable liposomal irinotecan with low toxicity and potent antitumor efficacy

Daryl C. Drummond, Charles O. Noble, IV, Zexiong Guo, Mark E. Hayes, Keelung Hong, John W. Park, Dmitri B. Kirpotin

Cancer Res (2005) 65 (9_Supplement): 330.

Published: 01 May 2005

View articletitled, Development of a highly stable liposomal irinotecan with low toxicity and potent antitumor efficacy

Journal Articles

Anti-EGFR immunoliposomes mediate specific and efficient drug delivery to target cells and can overcome multidrug-resistance

Christoph Mamot, Willy Kueng, Reto Ritschard, Juergen Reuter, Richard Herrmann, Charles Noble, Daryl Drummond, Dmitri Kirpotin, Christoph Rochlitz, John W. Park

Cancer Res (2005) 65 (9_Supplement): 334.

Published: 01 May 2005

View articletitled, Anti-EGFR immunoliposomes mediate specific and efficient drug delivery to target cells and can overcome multidrug-resistance

Journal Articles

A Phase 1 study using autologous antigen presenting cells loaded with BA7072 (APC8024) to treat subjects with metastatic breast cancer that over expresses HER-2/neu

Lori A. Jones, Michelle E. Melisko, Jami Breen Wollan, Lisa D. Johnson, Jennafer Carlin, Jelle Kylstra, Reiner Laus, John W. Park

Cancer Res (2004) 64 (7_Supplement): 281.

Published: 01 April 2004

View articletitled, A Phase 1 study using autologous antigen presenting cells loaded with BA7072 (APC8024) to treat subjects with metastatic breast cancer that over expresses HER-2/neu

Journal Articles

A comparison of RNA amplification techniques at low-input concentration

Julie E. Lang, Janet H. Scott, David G. Ginzinger, Gang Wang, Michael Makrigiorgos, Akpene A. Gbegnon, Julia R. Crothers, Daisuke F. Nonaka, Daniel B. Khodabakhsh, John W. Park, Laura J. Esserman, Chris M. Haqq

Cancer Res (2004) 64 (7_Supplement): 380.

Published: 01 April 2004

View articletitled, A comparison of RNA amplification techniques at low-input concentration

Journal Articles

Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging

Ryuta Saito, John R. Bringas, Tracy R. McKnight, Michael F. Wendland, Christoph Mamot, Daryl C. Drummond, Dmitri B. Kirpotin, John W. Park, Mitchel S. Berger, Krys S. Bankiewicz

Cancer Res (2004) 64 (7): 2572–2579.

https://doi.org/10.1158/0008-5472.CAN-03-3631

Published: 01 April 2004

View articletitled, Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract PS2-19: Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC)

Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer

Abstract P3-06-15: Evaluation of HER family protein signaling network as a predictive biomarker for pCR for breast cancer patients treated with neratinib in the I-SPY 2 trial

Abstract P3-06-29: MammaPrint High1/High2 risk class as a biomarker of response to neratinib plus standard neoadjuvant therapy for breast cancer in the I-SPY 2 TRIAL

Abstract CT227: Neratinib plus standard neoadjuvant therapy for high-risk breast cancer: Efficacy results from the I-SPY 2 TRIAL

Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis

Genomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer Patients

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Anthracylines can bypass multidrug-resistance mechanisms via receptor-specific immunoliposomal delivery in EGFR overexpressing tumor cells

Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy

Novel Nanoliposomal CPT-11 Infused by Convection-Enhanced Delivery in Intracranial Tumors: Pharmacology and Efficacy

Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs In vivo

Breast cancer phenotypes and responsiveness to bortezomib therapy.

Development of novel liposomal and receptor tyrosine kinase-targeted immunoliposomal vinorelbine formulations with improved drug retention

Liposomal and immunoliposomal therapeutics for brain tumors: biodistribution, imaging, and efficacy following convection-enhanced delivery

Development of a highly stable liposomal irinotecan with low toxicity and potent antitumor efficacy

Anti-EGFR immunoliposomes mediate specific and efficient drug delivery to target cells and can overcome multidrug-resistance

A Phase 1 study using autologous antigen presenting cells loaded with BA7072 (APC8024) to treat subjects with metastatic breast cancer that over expresses HER-2/neu

A comparison of RNA amplification techniques at low-input concentration

Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only